Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
NASDAQ Global Market · Equity
$44.5939
+$0.5639 · +1.28%
· Aug 21, 4:00 PM ET
$44.5939
Previous close+$0.5639 · +1.28%
· Aug 21, 4:00 PM ET
$44.64
+$0.61 · +1.39%
Regular session · ET · Market data may be delayed.
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
Fund assets
215.38M USD
Expense ratio
0.99%
NAV
$44.50
Average volume
30.49K
Volume
13.32K
Day range
$44.025 – $47.00
52-week range
$26.29 – $47.00
Previous close
$44.03
Price change
1 day
+1.28%
1 month
+7.98%
3 months
+16.98%
Year to date
+28.44%
1 year
+69.24%
3 years
+77.74%
5 years
+82.24%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 23, 2026.
Portfolio composition
Fund income
Dec 10, 2025
Annual
Dec 10, 2025
Dec 11, 2025
$0.0196
Dec 11, 2024
Annual
Dec 11, 2024
Dec 12, 2024
$0.7283
Dec 13, 2023
Annual
Dec 14, 2023
Dec 15, 2023
$0.1491
Latest coverage
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
